Comparative molecular field analysis (CoMFA) and docking studies of non- nucleoside HIV-1 RT inhibitors (NNIs)

Bioorganic and Medicinal Chemistry

Volumn 7, Issue 11, 1999, Pages 2283-2292

  Barreca, M L ^a   Carotti, A ^b   Carrieri, A ^b   Chimirri, A ^a   Monforte, A M ^c   Pellegrini Calace, M ^b   Rao, A ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANALYTIC METHOD; ARTICLE; DRUG ACTIVITY; DRUG BINDING; DRUG POTENCY; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS; LIPOPHILICITY; STRUCTURE ACTIVITY RELATION;

BENZIMIDAZOLES; BENZODIAZEPINES; CRYSTALLOGRAPHY, X-RAY; HIV-1 REVERSE TRANSCRIPTASE; IMIDAZOLES; MODELS, CHEMICAL; MODELS, MOLECULAR; PROTEIN CONFORMATION; REVERSE TRANSCRIPTASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033491040     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00181-9     Document Type: Article

References (37)

1. De Clercq E. Med. Res. Rev. 16:1996;125.
2. Chimirri A., Grasso S., Monforte A.M., Monforte P., Zappalà M. Il Farmaco. 46:1991;817.
3. Chimirri A., Grasso S., Monforte A.M., Monforte P., Zappalà M. Il Farmaco. 46:1991;925.
4. Schultz R.J., Bader J.P., Chimirri A., Covey J.M., Hill D.L., Haugwitz R.D., Guziec F.S., Narayanan V.L. Proc. Am. Assoc. Cancer Res. 33:1992;519.
5. Monforte P., Monforte A.M., Zappalà M., Romeo G., Grasso S., Chimirri A. US Patent. 5:1993;217, 984.
6. Chimirri A., Grasso S., Molica C., Monforte A.M., Monforte P., Zappalà M., Bruno G., Nicolò R., Witvrouw M., Jonckeere H., Balzarini J., De Clereq E. Antiviral Chem. Chemother. 8:1997;363.
7. Chimirri A., Grasso S., Monforte A.M., Monforte P., Rao A., Zappalà M., Bruno G., Nicolò F., Pannecouque C., Witvrouw M., De Clercq E. Antiviral Chem. Chemother. 9:1998;431.
8. Ding J., Das K., Moereels H., Koymans L., Andries K., Janssen P.A.J., Hugles S.H., Arnold E. Struct. Biol. 2:1995;407.
9. Tripos Inc., St. Louis, Missouri.
10. McMartin C., Bohacek R.S. J. Comp. Aid. Mol. Des. 11:1997;333.
11. Cramer R.D., Patterson D.E., Bunce J.D. J. Am. Chem. Soc. 110:1988;5959.
12. Dunn W.J., Mold S., Edlund U., Hellberg S., Gasteiger J. Quant. Struct. -Act. Relat. 3:1984;131.
13. Gaillard P., Carrupt P.-A., Testa B., Boundon A. J. Comp. -Aid. Mol. Des. 8:1994;83.
14. Testa B., Carrupt P.-A., Gaillard P., Billois F., Weber P. Pharm. Res. 13:1996;126.
15. Esnouf R., Ren J., Ross C., Jones Y., Stamners D., Stuart D. Struct. Biol. 2:1995;303.
16. Kukla M.J., Breslin H., Diamond C.J., Grous P.P., Ho C.Y., Miranda M., Rodgers J.D., Sherrill R.G., De Clercq E., Pauwels R., Andries K., Moens L.J., Janssen M.A.C., Janssen P.A.J. J. Med. Chem. 34:1991;3187.
17. Breslin H.J., Kukla M.J., Ludovici D.W., Mohrbacher R., Ho W., Miranda M., Rodgers J.D., Hitchens T.K., Leo G., Gauthier D.A., Ho C.Y., Scott M.K., De Clercq E., Pauwels R., Andries K., Janssen M.A.C., Janssen P.A.J. J. Med. Chem. 38:1995;771.
18. Ho W., Kukla M.J., Breslin H.J., Ludovici D.W., Grous P.P., Diamond C.J., Miranda M., Rodgers J.D., Ho C.Y., De Clercq E., Pauwels R., Andries K., Janssen M.A.C., Janssen P.A.J. J. Med. Chem. 38:1995;794.
19. Spence R.A., Kati W.M., Anderson K.S., Johnson K.A. Science. 267:1995;988.
20. Gupta S.P., Garg R. J. Enz. Inhib. 11:1996;23.
21. MOPAC6.0 is available from QCPE (506).
22. Mager P. P. Med. Res. Rev. 17:1997;235.
23. Tantillo C., Ding J., Jacobo-Molina A., Nanni R.G., Boyer P.L., Hughes S.H., Pauwels R., Andries K., Janssen P.A.J., Arnold E. J. Mol. Biol. 243:1994;369.
24. Metropolis N., Rosenbluth A.W., Rosenbluth M.N., Teller A.H., Teller E. J. Chem. Phys. 21:1953;1087.
25. Weiner S.J., Kollmann P.A., Case A.D., Singh U.C., Ghio C., Algona G., Profeta S., Weiner P. J. Am. Chem. Soc. 106:1984;765.
26. Polak E., Rebiere G. Rev. Franc. Inf. Rech. Oper. 16:1969;35.
27. Nishio, M., Hirota, M., Umezawa, Y., The CH-Pi Interaction: Evidence, Nature, and Consequences; Paperback, 1998.
28. Carrieri A., Altomare C., Barreca M.L., Contento A., Carotti A., Hansch C. Il Farmaco. 49:1994;573.
29. Carrieri A., Brasili L., Leonetti F., Pigini M., Giannella M., Bousquet P., Carotti A. Bioorg. Med. Chem. 5:1997;843.
30. Pigini M., Bousquet P., Brasili L., Carrieri A., Cavagna R., Dontwill M., Gentili F., Giannella M., Leonetti F., Piergentili A., Quaglia W., Carotti A. Bioorg. Med. Chem. 6:1998;2245.
31. Broto P., Moreau G., Vandyeke C. Eur. J. Med. Chem. 19:1984;61.
32. Agarwal A., Pearson P.P., Taylor E.W., Li H.B., Dahlgren T., Hersolf M., Yang Y., Lambert G., Nelson D.L., Regan J.W., Martin A.R. J. Med. Chem. 36:1993;4006.
33. Gussio R., Pattarbiraman N., Zaharevitz D.W., Kellogg G.E., Topol I.A., Rice W.G., Schaeffer C.A., Erickson J.W., Burt S.K. J. Med. Chem. 39:1996;1645.
34. Das K., Ding J., Hsiou Y., Clark A.D. Jr., Moereels H., Koymans L., Andries K., Pawels R., Janssen P.A., Boyer P.L., Clark P., Smith R.H. Jr., Kroeger Smith M.B., Michejda C.J., Hughes S.H., Arnold E. J. Mol. Biol. 264:1996;1085.
35. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. J. Appl. Cryst. 26:1993;283.
36. Halgren, T.A. J. Comp. Chem., 1996, 17.
37. Laskowski R.A. J. Mol. Graph. 13:1995;323.